Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Hypoglycemia | 29 | 2023 | 861 | 9.920 |
Why?
|
Gastric Bypass | 29 | 2024 | 812 | 7.050 |
Why?
|
Bariatric Surgery | 20 | 2024 | 952 | 5.140 |
Why?
|
Obesity, Morbid | 18 | 2023 | 1213 | 2.560 |
Why?
|
Insulin Resistance | 33 | 2024 | 3864 | 2.550 |
Why?
|
Insulin | 44 | 2023 | 6580 | 2.400 |
Why?
|
Insulinoma | 4 | 2023 | 124 | 2.380 |
Why?
|
Obesity | 40 | 2023 | 12745 | 2.160 |
Why?
|
Diabetes Mellitus, Type 2 | 42 | 2024 | 11725 | 2.100 |
Why?
|
Glucagon | 6 | 2022 | 533 | 1.570 |
Why?
|
Blood Glucose | 36 | 2023 | 6256 | 1.560 |
Why?
|
Glucose Intolerance | 10 | 2016 | 577 | 1.410 |
Why?
|
Glucose | 17 | 2022 | 4397 | 1.410 |
Why?
|
Receptor, Insulin | 12 | 2016 | 846 | 1.210 |
Why?
|
Adipose Tissue, Brown | 5 | 2023 | 757 | 1.200 |
Why?
|
Fibroblast Growth Factors | 5 | 2022 | 879 | 1.200 |
Why?
|
Bile Acids and Salts | 6 | 2017 | 367 | 1.160 |
Why?
|
Liver | 19 | 2021 | 7474 | 1.150 |
Why?
|
Energy Metabolism | 13 | 2019 | 2899 | 1.000 |
Why?
|
Muscle, Skeletal | 19 | 2020 | 4931 | 0.980 |
Why?
|
Gastrectomy | 7 | 2022 | 663 | 0.980 |
Why?
|
Diabetes Mellitus, Type 1 | 8 | 2024 | 3336 | 0.960 |
Why?
|
Insulin Antagonists | 1 | 2023 | 20 | 0.930 |
Why?
|
Malnutrition | 7 | 2017 | 625 | 0.890 |
Why?
|
Islets of Langerhans | 9 | 2014 | 1352 | 0.870 |
Why?
|
Bariatrics | 1 | 2023 | 34 | 0.870 |
Why?
|
Insulin-Secreting Cells | 5 | 2017 | 891 | 0.850 |
Why?
|
Hyperinsulinism | 4 | 2016 | 415 | 0.850 |
Why?
|
Islet Amyloid Polypeptide | 1 | 2022 | 41 | 0.840 |
Why?
|
Receptors, Glucagon | 2 | 2014 | 92 | 0.830 |
Why?
|
Metabolic Diseases | 4 | 2019 | 658 | 0.830 |
Why?
|
Mitochondria, Muscle | 2 | 2017 | 171 | 0.820 |
Why?
|
Adipocytes | 10 | 2022 | 1184 | 0.810 |
Why?
|
Gene Expression Regulation | 17 | 2021 | 12072 | 0.800 |
Why?
|
Anti-Obesity Agents | 2 | 2023 | 217 | 0.790 |
Why?
|
Prenatal Exposure Delayed Effects | 9 | 2019 | 2408 | 0.760 |
Why?
|
Human Growth Hormone | 2 | 2022 | 683 | 0.730 |
Why?
|
Lipid Metabolism | 10 | 2019 | 1889 | 0.720 |
Why?
|
Birth Weight | 9 | 2019 | 2069 | 0.720 |
Why?
|
Pancreatic Neoplasms | 4 | 2023 | 5256 | 0.720 |
Why?
|
Blood Glucose Self-Monitoring | 6 | 2023 | 434 | 0.710 |
Why?
|
AMP-Activated Protein Kinases | 4 | 2021 | 611 | 0.690 |
Why?
|
Metabolome | 4 | 2021 | 895 | 0.690 |
Why?
|
Epigenesis, Genetic | 8 | 2022 | 3647 | 0.680 |
Why?
|
Metabolism | 2 | 2020 | 196 | 0.680 |
Why?
|
Sodium-Glucose Transporter 2 | 1 | 2019 | 85 | 0.660 |
Why?
|
Weight Loss | 5 | 2022 | 2622 | 0.650 |
Why?
|
Incretins | 3 | 2022 | 88 | 0.620 |
Why?
|
Receptors, G-Protein-Coupled | 2 | 2023 | 1222 | 0.610 |
Why?
|
Oxidative Phosphorylation | 4 | 2010 | 481 | 0.600 |
Why?
|
Muscle Fibers, Skeletal | 6 | 2016 | 555 | 0.600 |
Why?
|
Adipocytes, White | 1 | 2018 | 89 | 0.600 |
Why?
|
Hypoglycemic Agents | 11 | 2024 | 2872 | 0.600 |
Why?
|
Postoperative Complications | 8 | 2021 | 15295 | 0.590 |
Why?
|
Alanine | 2 | 2018 | 572 | 0.570 |
Why?
|
Growth | 3 | 2009 | 376 | 0.540 |
Why?
|
Induced Pluripotent Stem Cells | 3 | 2016 | 1736 | 0.530 |
Why?
|
Fatty Liver | 5 | 2019 | 727 | 0.520 |
Why?
|
Umbilical Cord | 1 | 2016 | 180 | 0.520 |
Why?
|
Gastrointestinal Agents | 1 | 2020 | 494 | 0.510 |
Why?
|
Humans | 124 | 2024 | 744343 | 0.510 |
Why?
|
Iodide Peroxidase | 6 | 2015 | 293 | 0.490 |
Why?
|
Proteome | 2 | 2021 | 1799 | 0.490 |
Why?
|
Animals | 72 | 2023 | 168757 | 0.480 |
Why?
|
Maternal Nutritional Physiological Phenomena | 3 | 2016 | 378 | 0.480 |
Why?
|
Triiodothyronine | 4 | 2011 | 494 | 0.470 |
Why?
|
Mice, Inbred ICR | 8 | 2017 | 352 | 0.470 |
Why?
|
Metabolomics | 3 | 2018 | 1484 | 0.460 |
Why?
|
Hyperglycemia | 1 | 2022 | 1373 | 0.450 |
Why?
|
Lipogenesis | 3 | 2011 | 212 | 0.450 |
Why?
|
Fasting | 6 | 2021 | 1593 | 0.450 |
Why?
|
Mitochondria | 4 | 2016 | 3520 | 0.440 |
Why?
|
Fatty Acids, Nonesterified | 3 | 2015 | 402 | 0.440 |
Why?
|
Terminology as Topic | 1 | 2020 | 1547 | 0.440 |
Why?
|
Pregnancy Complications | 4 | 2016 | 2861 | 0.430 |
Why?
|
Intestines | 2 | 2019 | 1924 | 0.430 |
Why?
|
Nuclear Proteins | 4 | 2022 | 5853 | 0.430 |
Why?
|
Family Characteristics | 1 | 2017 | 1000 | 0.410 |
Why?
|
Mothers | 3 | 2019 | 2165 | 0.410 |
Why?
|
Phosphatidate Phosphatase | 1 | 2011 | 21 | 0.410 |
Why?
|
DNA Methylation | 6 | 2019 | 4286 | 0.400 |
Why?
|
Mice | 47 | 2023 | 81183 | 0.400 |
Why?
|
Biosensing Techniques | 3 | 2022 | 668 | 0.400 |
Why?
|
Serum Response Factor | 1 | 2011 | 81 | 0.380 |
Why?
|
Amino Acids | 5 | 2018 | 1736 | 0.380 |
Why?
|
Adipose Tissue | 6 | 2022 | 3279 | 0.370 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2019 | 2016 | 0.360 |
Why?
|
Male | 76 | 2024 | 350118 | 0.360 |
Why?
|
Palmitic Acid | 2 | 2008 | 154 | 0.360 |
Why?
|
Palmitates | 1 | 2009 | 74 | 0.350 |
Why?
|
Prediabetic State | 4 | 2018 | 499 | 0.350 |
Why?
|
Endocannabinoids | 1 | 2010 | 116 | 0.350 |
Why?
|
Female | 74 | 2024 | 380194 | 0.340 |
Why?
|
Receptor, Cannabinoid, CB1 | 1 | 2010 | 143 | 0.340 |
Why?
|
Eating | 2 | 2007 | 1536 | 0.340 |
Why?
|
Insulin Receptor Substrate Proteins | 9 | 2013 | 563 | 0.340 |
Why?
|
Fetal Growth Retardation | 3 | 2008 | 570 | 0.340 |
Why?
|
Thyroid Hormones | 2 | 2010 | 390 | 0.340 |
Why?
|
Infant, Low Birth Weight | 3 | 2014 | 850 | 0.340 |
Why?
|
Signal Transduction | 18 | 2021 | 23403 | 0.330 |
Why?
|
Pregnancy | 21 | 2023 | 29144 | 0.330 |
Why?
|
Animals, Newborn | 4 | 2011 | 2726 | 0.330 |
Why?
|
Fetal Blood | 1 | 2015 | 1318 | 0.320 |
Why?
|
Body Mass Index | 13 | 2024 | 12720 | 0.320 |
Why?
|
Antigens, CD | 2 | 2016 | 4026 | 0.320 |
Why?
|
Gastrointestinal Hormones | 2 | 2019 | 97 | 0.310 |
Why?
|
Carbohydrate Metabolism | 3 | 2018 | 264 | 0.310 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2008 | 697 | 0.300 |
Why?
|
E2F4 Transcription Factor | 2 | 2006 | 36 | 0.300 |
Why?
|
Receptors, Thyroid Hormone | 1 | 2008 | 202 | 0.300 |
Why?
|
Nerve Tissue Proteins | 3 | 2011 | 4462 | 0.290 |
Why?
|
Betaine | 2 | 2018 | 87 | 0.290 |
Why?
|
Trans-Activators | 2 | 2009 | 2924 | 0.290 |
Why?
|
Transcription Factors | 9 | 2022 | 12208 | 0.290 |
Why?
|
Fatty Acids | 2 | 2008 | 1809 | 0.280 |
Why?
|
Glucagon-Like Peptide 1 | 3 | 2019 | 340 | 0.280 |
Why?
|
Dyslipidemias | 1 | 2013 | 849 | 0.270 |
Why?
|
Phosphoproteins | 8 | 2002 | 2440 | 0.270 |
Why?
|
Peptide Fragments | 2 | 2019 | 5097 | 0.270 |
Why?
|
Diabetes Mellitus, Experimental | 5 | 2011 | 1116 | 0.260 |
Why?
|
Triglycerides | 5 | 2014 | 2454 | 0.260 |
Why?
|
Lipids | 3 | 2019 | 3305 | 0.260 |
Why?
|
Diet, Reducing | 2 | 2006 | 462 | 0.260 |
Why?
|
Peroxisome Proliferator-Activated Receptors | 2 | 2007 | 65 | 0.260 |
Why?
|
Insulin-Like Growth Factor Binding Protein 1 | 2 | 2024 | 123 | 0.260 |
Why?
|
Postprandial Period | 2 | 2021 | 292 | 0.250 |
Why?
|
Prenatal Nutritional Physiological Phenomena | 2 | 2017 | 159 | 0.250 |
Why?
|
Energy Intake | 3 | 2017 | 2148 | 0.250 |
Why?
|
Cell Survival | 1 | 2015 | 5882 | 0.250 |
Why?
|
Adult | 39 | 2024 | 214055 | 0.240 |
Why?
|
Dietary Fats | 6 | 2017 | 2017 | 0.240 |
Why?
|
Glucosamine | 2 | 2007 | 132 | 0.240 |
Why?
|
Mesenchymal Stem Cells | 1 | 2015 | 1632 | 0.240 |
Why?
|
Dietary Carbohydrates | 2 | 2017 | 906 | 0.240 |
Why?
|
Muscles | 2 | 2006 | 1614 | 0.240 |
Why?
|
Cell Proliferation | 2 | 2017 | 10481 | 0.240 |
Why?
|
Mice, Inbred C57BL | 16 | 2021 | 21827 | 0.230 |
Why?
|
Gastroplasty | 2 | 2019 | 142 | 0.230 |
Why?
|
Thiazolidinediones | 2 | 2008 | 476 | 0.230 |
Why?
|
Middle Aged | 34 | 2024 | 213383 | 0.230 |
Why?
|
Glucose Tolerance Test | 4 | 2015 | 1150 | 0.230 |
Why?
|
Carrier Proteins | 4 | 2021 | 5021 | 0.230 |
Why?
|
Growth Hormone | 2 | 2024 | 705 | 0.230 |
Why?
|
Disease Susceptibility | 2 | 2008 | 1782 | 0.230 |
Why?
|
Gastric Inhibitory Polypeptide | 2 | 2017 | 59 | 0.220 |
Why?
|
Glucagon-Like Peptides | 1 | 2024 | 127 | 0.220 |
Why?
|
Insulin-Like Growth Factor I | 4 | 2024 | 2015 | 0.220 |
Why?
|
Spermatozoa | 2 | 2019 | 625 | 0.220 |
Why?
|
Gene Expression Regulation, Developmental | 4 | 2012 | 3617 | 0.210 |
Why?
|
Laparoscopy | 3 | 2019 | 2151 | 0.210 |
Why?
|
Postoperative Period | 2 | 2019 | 1842 | 0.210 |
Why?
|
RNA-Binding Proteins | 1 | 2011 | 1903 | 0.210 |
Why?
|
Dipeptidases | 1 | 2021 | 38 | 0.210 |
Why?
|
Primary Dysautonomias | 1 | 2022 | 29 | 0.210 |
Why?
|
Ribosomal Protein S6 Kinases | 3 | 1999 | 205 | 0.200 |
Why?
|
Adipogenesis | 2 | 2023 | 359 | 0.200 |
Why?
|
Insulin-Like Growth Factor Binding Protein 2 | 1 | 2021 | 76 | 0.200 |
Why?
|
Rodentia | 1 | 2023 | 261 | 0.200 |
Why?
|
Islets of Langerhans Transplantation | 4 | 2014 | 745 | 0.200 |
Why?
|
Enzyme Activation | 6 | 2008 | 3701 | 0.190 |
Why?
|
Phospholipases A2, Calcium-Independent | 1 | 2020 | 9 | 0.190 |
Why?
|
Immunoassay | 4 | 2022 | 752 | 0.190 |
Why?
|
Up-Regulation | 4 | 2019 | 4217 | 0.190 |
Why?
|
Models, Animal | 4 | 2013 | 2171 | 0.190 |
Why?
|
Mitochondrial Proteins | 1 | 2007 | 996 | 0.190 |
Why?
|
Diabetes Mellitus | 5 | 2018 | 5751 | 0.180 |
Why?
|
Adiposity | 4 | 2019 | 1807 | 0.180 |
Why?
|
Risk Factors | 15 | 2021 | 72290 | 0.180 |
Why?
|
Stem Cells | 2 | 2011 | 3567 | 0.180 |
Why?
|
Hexosamines | 1 | 1999 | 42 | 0.180 |
Why?
|
Food | 2 | 2007 | 771 | 0.180 |
Why?
|
Wound Healing | 1 | 2011 | 2785 | 0.180 |
Why?
|
Adiponectin | 6 | 2024 | 1100 | 0.180 |
Why?
|
MAP Kinase Signaling System | 1 | 2007 | 1526 | 0.180 |
Why?
|
Fructose | 1 | 2001 | 288 | 0.170 |
Why?
|
Gene Expression Profiling | 10 | 2022 | 9438 | 0.170 |
Why?
|
Mice, Knockout | 13 | 2021 | 14557 | 0.170 |
Why?
|
Needles | 1 | 2022 | 449 | 0.170 |
Why?
|
Paternal Exposure | 1 | 2019 | 89 | 0.170 |
Why?
|
Paternal Behavior | 1 | 2018 | 32 | 0.170 |
Why?
|
Feeding Behavior | 3 | 2017 | 3188 | 0.160 |
Why?
|
Diglycerides | 1 | 2019 | 176 | 0.160 |
Why?
|
Phosphatidylinositol 3-Kinases | 10 | 2008 | 2938 | 0.160 |
Why?
|
Superoxide Dismutase | 1 | 2021 | 597 | 0.160 |
Why?
|
Gene Expression | 5 | 2010 | 7799 | 0.160 |
Why?
|
Rats | 9 | 2021 | 24260 | 0.160 |
Why?
|
Adaptor Proteins, Signal Transducing | 3 | 1999 | 2916 | 0.160 |
Why?
|
Intermittent Claudication | 1 | 2020 | 309 | 0.160 |
Why?
|
Hepatocytes | 2 | 2021 | 1211 | 0.160 |
Why?
|
Ketones | 1 | 2019 | 188 | 0.150 |
Why?
|
Phosphorylation | 7 | 2011 | 8436 | 0.150 |
Why?
|
Hep G2 Cells | 1 | 2018 | 393 | 0.150 |
Why?
|
Clinical Alarms | 1 | 2017 | 51 | 0.150 |
Why?
|
C-Peptide | 3 | 2024 | 419 | 0.150 |
Why?
|
Metformin | 1 | 2024 | 835 | 0.140 |
Why?
|
DNA, Mitochondrial | 2 | 2015 | 817 | 0.140 |
Why?
|
Mitochondrial Size | 1 | 2016 | 8 | 0.140 |
Why?
|
Citrate (si)-Synthase | 1 | 2016 | 43 | 0.140 |
Why?
|
Fathers | 1 | 2019 | 358 | 0.140 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2019 | 648 | 0.140 |
Why?
|
Cells, Cultured | 11 | 2021 | 19229 | 0.140 |
Why?
|
Case-Control Studies | 6 | 2020 | 21746 | 0.140 |
Why?
|
Drug Monitoring | 1 | 2022 | 956 | 0.140 |
Why?
|
Quality of Life | 2 | 2019 | 12804 | 0.130 |
Why?
|
Nutrition Therapy | 1 | 2017 | 96 | 0.130 |
Why?
|
Pancreas | 2 | 2017 | 1686 | 0.130 |
Why?
|
Appetite | 1 | 2017 | 243 | 0.130 |
Why?
|
Minerals | 1 | 2017 | 275 | 0.130 |
Why?
|
Epigenomics | 2 | 2018 | 903 | 0.130 |
Why?
|
Antibodies | 1 | 2023 | 2460 | 0.130 |
Why?
|
Caloric Restriction | 2 | 2014 | 302 | 0.130 |
Why?
|
Physical Conditioning, Animal | 1 | 2018 | 362 | 0.130 |
Why?
|
Cell Line | 4 | 2018 | 15997 | 0.130 |
Why?
|
Disease Models, Animal | 5 | 2020 | 18029 | 0.130 |
Why?
|
Fetal Nutrition Disorders | 1 | 2014 | 8 | 0.130 |
Why?
|
Vagus Nerve | 1 | 2017 | 438 | 0.120 |
Why?
|
Inheritance Patterns | 1 | 2017 | 340 | 0.120 |
Why?
|
Infant | 7 | 2019 | 35136 | 0.120 |
Why?
|
Sirolimus | 2 | 2019 | 1564 | 0.120 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2029 | 0.120 |
Why?
|
Glucagon-Secreting Cells | 1 | 2014 | 41 | 0.120 |
Why?
|
Blood Proteins | 1 | 2019 | 1124 | 0.120 |
Why?
|
Citric Acid Cycle | 2 | 2007 | 232 | 0.120 |
Why?
|
DNA-Binding Proteins | 3 | 2018 | 9648 | 0.120 |
Why?
|
Arginine | 2 | 2014 | 944 | 0.120 |
Why?
|
Randomized Controlled Trials as Topic | 4 | 2024 | 9959 | 0.120 |
Why?
|
Taurine | 1 | 2014 | 94 | 0.120 |
Why?
|
Placenta | 2 | 2021 | 1698 | 0.110 |
Why?
|
Oxidation-Reduction | 2 | 2009 | 2187 | 0.110 |
Why?
|
Dumping Syndrome | 2 | 2019 | 18 | 0.110 |
Why?
|
Infant, Newborn | 6 | 2019 | 25625 | 0.110 |
Why?
|
Absorptiometry, Photon | 2 | 2011 | 1725 | 0.110 |
Why?
|
Cell Lineage | 1 | 2022 | 2504 | 0.110 |
Why?
|
Body Weight | 3 | 2013 | 4669 | 0.110 |
Why?
|
Cohort Studies | 6 | 2016 | 40561 | 0.110 |
Why?
|
Caffeine | 1 | 2017 | 699 | 0.100 |
Why?
|
Adenosine Triphosphate | 1 | 2018 | 2025 | 0.100 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2018 | 2214 | 0.100 |
Why?
|
Down-Regulation | 2 | 2016 | 3002 | 0.100 |
Why?
|
Dietary Proteins | 1 | 2017 | 963 | 0.100 |
Why?
|
Ischemia | 1 | 2020 | 1907 | 0.100 |
Why?
|
Thyroid Diseases | 1 | 2015 | 379 | 0.100 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.100 |
Why?
|
Nutritional Status | 2 | 2011 | 1609 | 0.100 |
Why?
|
Hypolipidemic Agents | 1 | 2015 | 604 | 0.100 |
Why?
|
Exercise | 3 | 2021 | 5615 | 0.100 |
Why?
|
Taurochenodeoxycholic Acid | 1 | 2011 | 34 | 0.100 |
Why?
|
Protein Kinase C-delta | 1 | 2011 | 123 | 0.100 |
Why?
|
Hypercholesterolemia | 1 | 2018 | 1151 | 0.100 |
Why?
|
Phenylbutyrates | 1 | 2011 | 69 | 0.090 |
Why?
|
Reward | 1 | 2017 | 941 | 0.090 |
Why?
|
Leptin | 3 | 2014 | 1599 | 0.090 |
Why?
|
Lactic Acid | 1 | 2016 | 1133 | 0.090 |
Why?
|
Fetal Development | 1 | 2016 | 767 | 0.090 |
Why?
|
Thyroid Hormone Receptors beta | 1 | 2010 | 21 | 0.090 |
Why?
|
Cardiovascular Diseases | 2 | 2014 | 15165 | 0.090 |
Why?
|
PPAR gamma | 3 | 2008 | 493 | 0.090 |
Why?
|
Genomic Imprinting | 1 | 2012 | 328 | 0.090 |
Why?
|
Postoperative Care | 1 | 2017 | 1486 | 0.090 |
Why?
|
Environment | 1 | 2016 | 1124 | 0.090 |
Why?
|
Appetite Regulation | 1 | 2010 | 88 | 0.090 |
Why?
|
Dietary Supplements | 3 | 2018 | 3297 | 0.090 |
Why?
|
Tumor Suppressor Proteins | 1 | 2020 | 2849 | 0.090 |
Why?
|
Mice, Inbred NOD | 2 | 2007 | 1878 | 0.090 |
Why?
|
Pyrazines | 1 | 2015 | 1230 | 0.090 |
Why?
|
Autoradiography | 1 | 2010 | 745 | 0.090 |
Why?
|
Peripheral Arterial Disease | 1 | 2020 | 1188 | 0.090 |
Why?
|
Phenotype | 3 | 2017 | 16365 | 0.090 |
Why?
|
Aryl Hydrocarbon Receptor Nuclear Translocator | 1 | 2009 | 38 | 0.090 |
Why?
|
Aged | 11 | 2020 | 163280 | 0.090 |
Why?
|
Midline Thalamic Nuclei | 1 | 2009 | 13 | 0.090 |
Why?
|
Algorithms | 3 | 2020 | 13881 | 0.090 |
Why?
|
Oxidative Stress | 3 | 2017 | 3086 | 0.090 |
Why?
|
Cell Size | 2 | 2009 | 643 | 0.080 |
Why?
|
CpG Islands | 1 | 2013 | 1172 | 0.080 |
Why?
|
3-Hydroxybutyric Acid | 1 | 2009 | 87 | 0.080 |
Why?
|
Triazenes | 1 | 2008 | 8 | 0.080 |
Why?
|
Muscle Development | 1 | 2011 | 271 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2020 | 12026 | 0.080 |
Why?
|
Organ Size | 2 | 2011 | 2252 | 0.080 |
Why?
|
Mesangial Cells | 1 | 2008 | 24 | 0.080 |
Why?
|
Acetates | 1 | 2010 | 311 | 0.080 |
Why?
|
Pluripotent Stem Cells | 1 | 2016 | 795 | 0.080 |
Why?
|
Bone Marrow | 1 | 2019 | 2948 | 0.080 |
Why?
|
Patient Education as Topic | 2 | 2017 | 2278 | 0.080 |
Why?
|
Hyperphagia | 1 | 2009 | 136 | 0.080 |
Why?
|
Liver Neoplasms | 2 | 2018 | 4253 | 0.080 |
Why?
|
Confusion | 1 | 2010 | 275 | 0.080 |
Why?
|
Oligonucleotide Array Sequence Analysis | 6 | 2010 | 3920 | 0.080 |
Why?
|
Intercellular Signaling Peptides and Proteins | 3 | 2005 | 1676 | 0.080 |
Why?
|
Treatment Outcome | 8 | 2024 | 63114 | 0.080 |
Why?
|
Reactive Oxygen Species | 1 | 2016 | 2077 | 0.080 |
Why?
|
Vitamins | 1 | 2017 | 1622 | 0.080 |
Why?
|
Ribonucleotides | 1 | 2008 | 117 | 0.080 |
Why?
|
Aminoimidazole Carboxamide | 1 | 2008 | 88 | 0.080 |
Why?
|
Central Nervous System Stimulants | 1 | 2017 | 1148 | 0.080 |
Why?
|
Epoxy Compounds | 1 | 2008 | 136 | 0.080 |
Why?
|
Genome | 1 | 2016 | 1808 | 0.080 |
Why?
|
Retrospective Studies | 3 | 2021 | 77449 | 0.080 |
Why?
|
STAT5 Transcription Factor | 1 | 2008 | 259 | 0.080 |
Why?
|
RNA, Messenger | 6 | 2011 | 13033 | 0.080 |
Why?
|
Receptors, Leptin | 1 | 2009 | 360 | 0.080 |
Why?
|
Suppressor of Cytokine Signaling Proteins | 1 | 2008 | 175 | 0.080 |
Why?
|
Syncope | 1 | 2010 | 429 | 0.070 |
Why?
|
GRB2 Adaptor Protein | 2 | 1998 | 103 | 0.070 |
Why?
|
Haplotypes | 1 | 2013 | 2779 | 0.070 |
Why?
|
Cell Differentiation | 5 | 2023 | 11483 | 0.070 |
Why?
|
Mice, Transgenic | 4 | 2011 | 9734 | 0.070 |
Why?
|
Cell Count | 1 | 2011 | 1856 | 0.070 |
Why?
|
Zinc Fingers | 1 | 2009 | 585 | 0.070 |
Why?
|
Homeostasis | 4 | 2016 | 3340 | 0.070 |
Why?
|
RNA Splicing | 1 | 2011 | 907 | 0.070 |
Why?
|
Weight Gain | 2 | 2015 | 2292 | 0.070 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2002 | 2915 | 0.070 |
Why?
|
Maternal-Fetal Exchange | 1 | 2008 | 456 | 0.070 |
Why?
|
Angiotensins | 1 | 2007 | 151 | 0.070 |
Why?
|
Malonyl Coenzyme A | 1 | 2006 | 20 | 0.070 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2008 | 430 | 0.070 |
Why?
|
Thermogenesis | 1 | 2010 | 435 | 0.070 |
Why?
|
Aging | 4 | 2013 | 8664 | 0.070 |
Why?
|
Pancreatectomy | 2 | 2014 | 804 | 0.070 |
Why?
|
Mice, Obese | 1 | 2007 | 424 | 0.070 |
Why?
|
Vanadates | 2 | 1995 | 82 | 0.070 |
Why?
|
Insurance Coverage | 1 | 2017 | 1901 | 0.070 |
Why?
|
Receptor, IGF Type 1 | 1 | 2008 | 390 | 0.070 |
Why?
|
Proteomics | 1 | 2019 | 3638 | 0.070 |
Why?
|
Cognition | 1 | 2023 | 6770 | 0.070 |
Why?
|
Transcription, Genetic | 5 | 2010 | 7722 | 0.070 |
Why?
|
Carboxy-Lyases | 1 | 2006 | 90 | 0.070 |
Why?
|
Hormones | 1 | 2010 | 889 | 0.070 |
Why?
|
In Situ Nick-End Labeling | 1 | 2007 | 643 | 0.070 |
Why?
|
Cytoskeleton | 1 | 2011 | 1185 | 0.070 |
Why?
|
Body Composition | 2 | 2015 | 2401 | 0.070 |
Why?
|
Diazoxide | 1 | 2005 | 57 | 0.070 |
Why?
|
3T3-L1 Cells | 1 | 2006 | 198 | 0.070 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2008 | 625 | 0.070 |
Why?
|
Biopsy | 2 | 2011 | 6756 | 0.070 |
Why?
|
Metabolic Networks and Pathways | 1 | 2010 | 783 | 0.070 |
Why?
|
Proto-Oncogene Proteins c-akt | 2 | 2008 | 2503 | 0.070 |
Why?
|
Thyrotropin | 1 | 2009 | 849 | 0.070 |
Why?
|
Animal Nutritional Physiological Phenomena | 1 | 2005 | 57 | 0.060 |
Why?
|
Heat-Shock Proteins | 1 | 2009 | 822 | 0.060 |
Why?
|
Mitochondrial Diseases | 1 | 2009 | 320 | 0.060 |
Why?
|
Octreotide | 1 | 2005 | 145 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 5 | 2009 | 17446 | 0.060 |
Why?
|
Ribosomal Protein S6 Kinases, 70-kDa | 1 | 2004 | 104 | 0.060 |
Why?
|
Diet Therapy | 1 | 2005 | 154 | 0.060 |
Why?
|
Sweetening Agents | 1 | 2007 | 296 | 0.060 |
Why?
|
Flow Cytometry | 1 | 2015 | 5974 | 0.060 |
Why?
|
Follow-Up Studies | 4 | 2024 | 39050 | 0.060 |
Why?
|
Nervous System Diseases | 1 | 2015 | 1622 | 0.060 |
Why?
|
Glucose Transporter Type 4 | 1 | 2004 | 250 | 0.060 |
Why?
|
Prevalence | 2 | 2019 | 15226 | 0.060 |
Why?
|
Cross-Sectional Studies | 4 | 2015 | 25043 | 0.060 |
Why?
|
Alcohol Drinking | 1 | 2017 | 3966 | 0.060 |
Why?
|
Nuclear Respiratory Factors | 1 | 2003 | 19 | 0.060 |
Why?
|
Benzhydryl Compounds | 1 | 2010 | 845 | 0.060 |
Why?
|
Nuclear Respiratory Factor 1 | 1 | 2003 | 23 | 0.060 |
Why?
|
NF-E2-Related Factor 1 | 1 | 2003 | 23 | 0.060 |
Why?
|
Fibroblasts | 1 | 2014 | 4161 | 0.060 |
Why?
|
Heart | 2 | 2015 | 4467 | 0.060 |
Why?
|
Litter Size | 1 | 2023 | 54 | 0.060 |
Why?
|
Cell Line, Tumor | 2 | 2011 | 16689 | 0.060 |
Why?
|
Actins | 1 | 2011 | 2121 | 0.060 |
Why?
|
Receptors, Cytoplasmic and Nuclear | 2 | 2009 | 871 | 0.060 |
Why?
|
Glycogen Synthase | 2 | 2000 | 62 | 0.060 |
Why?
|
Progeria | 1 | 2005 | 185 | 0.050 |
Why?
|
Monosaccharide Transport Proteins | 1 | 2004 | 440 | 0.050 |
Why?
|
Endoplasmic Reticulum | 1 | 2009 | 1144 | 0.050 |
Why?
|
Lipid Peroxidation | 1 | 2003 | 270 | 0.050 |
Why?
|
Mexican Americans | 1 | 2003 | 166 | 0.050 |
Why?
|
Pregnancy, Animal | 1 | 2003 | 134 | 0.050 |
Why?
|
Histone Deacetylases | 1 | 2007 | 728 | 0.050 |
Why?
|
Hyperplasia | 1 | 2005 | 1185 | 0.050 |
Why?
|
Regeneration | 1 | 2011 | 1485 | 0.050 |
Why?
|
Piperidines | 1 | 2010 | 1602 | 0.050 |
Why?
|
Severity of Illness Index | 2 | 2010 | 15540 | 0.050 |
Why?
|
Glycolysis | 2 | 2003 | 827 | 0.050 |
Why?
|
Cholesterol, HDL | 2 | 2005 | 1814 | 0.050 |
Why?
|
Clinical Trials as Topic | 1 | 2017 | 7913 | 0.050 |
Why?
|
Food, Formulated | 1 | 2001 | 109 | 0.050 |
Why?
|
Forkhead Transcription Factors | 1 | 2008 | 1613 | 0.050 |
Why?
|
Extracellular Fluid | 1 | 2022 | 167 | 0.050 |
Why?
|
Protein Kinases | 2 | 2006 | 1640 | 0.050 |
Why?
|
Fetus | 1 | 2008 | 1880 | 0.050 |
Why?
|
Vanadium Compounds | 1 | 2000 | 9 | 0.050 |
Why?
|
ras Proteins | 1 | 2006 | 1060 | 0.050 |
Why?
|
Trinucleotide Repeats | 1 | 2001 | 261 | 0.050 |
Why?
|
Chromosomes, Human, Pair 4 | 1 | 2001 | 374 | 0.050 |
Why?
|
Adipose Tissue, White | 1 | 2023 | 351 | 0.050 |
Why?
|
Arteriosclerosis | 1 | 2005 | 1092 | 0.050 |
Why?
|
Rats, Wistar | 2 | 2005 | 1901 | 0.050 |
Why?
|
Pyrazoles | 1 | 2010 | 1972 | 0.040 |
Why?
|
Myasthenia Gravis | 1 | 2002 | 199 | 0.040 |
Why?
|
Mixed Function Oxygenases | 1 | 2021 | 272 | 0.040 |
Why?
|
Proteins | 3 | 2003 | 6103 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1783 | 0.040 |
Why?
|
Adipocytes, Brown | 2 | 2011 | 144 | 0.040 |
Why?
|
Blood Vessels | 1 | 2005 | 1125 | 0.040 |
Why?
|
Calcium-Calmodulin-Dependent Protein Kinases | 2 | 1998 | 494 | 0.040 |
Why?
|
Myositis | 1 | 2002 | 251 | 0.040 |
Why?
|
Prognosis | 1 | 2020 | 29063 | 0.040 |
Why?
|
Gluconeogenesis | 2 | 2011 | 183 | 0.040 |
Why?
|
Phosphotransferases (Alcohol Group Acceptor) | 3 | 1997 | 437 | 0.040 |
Why?
|
Myocardium | 2 | 2015 | 4776 | 0.040 |
Why?
|
Oligonucleotides | 1 | 2022 | 572 | 0.040 |
Why?
|
Muscle Proteins | 1 | 2004 | 1159 | 0.040 |
Why?
|
C-Reactive Protein | 2 | 2014 | 3778 | 0.040 |
Why?
|
Receptors, Calcitriol | 1 | 2021 | 350 | 0.040 |
Why?
|
Polyenes | 1 | 1998 | 69 | 0.040 |
Why?
|
Environmental Exposure | 1 | 2013 | 4234 | 0.040 |
Why?
|
Phosphotransferases | 1 | 1999 | 308 | 0.040 |
Why?
|
Time Factors | 3 | 2010 | 40075 | 0.040 |
Why?
|
Seizures | 1 | 2010 | 2859 | 0.040 |
Why?
|
Ursodeoxycholic Acid | 1 | 2017 | 72 | 0.040 |
Why?
|
Patient Care Team | 1 | 2009 | 2531 | 0.040 |
Why?
|
Enzyme Inhibitors | 1 | 2008 | 3798 | 0.040 |
Why?
|
Tyrosine | 2 | 1999 | 1461 | 0.040 |
Why?
|
Cell Cycle Proteins | 2 | 1999 | 3462 | 0.040 |
Why?
|
Proto-Oncogene Proteins | 2 | 2021 | 4554 | 0.040 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2010 | 4751 | 0.040 |
Why?
|
Multivariate Analysis | 1 | 2010 | 12245 | 0.040 |
Why?
|
Endothelium, Vascular | 2 | 2006 | 4456 | 0.040 |
Why?
|
Remission Induction | 1 | 2022 | 2386 | 0.040 |
Why?
|
Inflammation | 1 | 2016 | 10638 | 0.040 |
Why?
|
Androstadienes | 1 | 1998 | 346 | 0.030 |
Why?
|
Incidence | 2 | 2007 | 20947 | 0.030 |
Why?
|
Glycosylation | 1 | 1999 | 1126 | 0.030 |
Why?
|
Repressor Proteins | 2 | 2023 | 3023 | 0.030 |
Why?
|
Gene Expression Regulation, Enzymologic | 1 | 2020 | 1213 | 0.030 |
Why?
|
Substrate Specificity | 1 | 1999 | 1801 | 0.030 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2015 | 15519 | 0.030 |
Why?
|
Interleukin-2 | 1 | 2002 | 1904 | 0.030 |
Why?
|
Corpus Striatum | 1 | 2001 | 1221 | 0.030 |
Why?
|
TOR Serine-Threonine Kinases | 1 | 2004 | 2109 | 0.030 |
Why?
|
Flavonoids | 1 | 1998 | 443 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2000 | 1285 | 0.030 |
Why?
|
Epilepsy | 1 | 2010 | 3310 | 0.030 |
Why?
|
Predictive Value of Tests | 1 | 2010 | 15076 | 0.030 |
Why?
|
Huntington Disease | 1 | 2001 | 1124 | 0.030 |
Why?
|
Protein Isoforms | 1 | 1999 | 1730 | 0.030 |
Why?
|
Threonine | 1 | 2015 | 279 | 0.030 |
Why?
|
Disease Progression | 2 | 2009 | 13284 | 0.030 |
Why?
|
Testis | 2 | 2013 | 803 | 0.030 |
Why?
|
Oxygen Consumption | 2 | 2011 | 1869 | 0.030 |
Why?
|
Carnitine | 1 | 2015 | 246 | 0.030 |
Why?
|
Computational Biology | 1 | 2006 | 3521 | 0.030 |
Why?
|
Placebos | 1 | 2018 | 1676 | 0.030 |
Why?
|
Aged, 80 and over | 1 | 2019 | 57776 | 0.030 |
Why?
|
Mitochondria, Heart | 1 | 2015 | 247 | 0.030 |
Why?
|
Walking | 1 | 2020 | 1180 | 0.030 |
Why?
|
Organ Specificity | 1 | 1998 | 2008 | 0.030 |
Why?
|
Genomics | 1 | 2009 | 5720 | 0.030 |
Why?
|
Pancreatic Ducts | 1 | 2014 | 328 | 0.030 |
Why?
|
Mice, Inbred BALB C | 1 | 2001 | 6386 | 0.030 |
Why?
|
Sex Characteristics | 1 | 2003 | 2585 | 0.030 |
Why?
|
Phosphotyrosine | 3 | 1999 | 457 | 0.030 |
Why?
|
Pancreatic Diseases | 1 | 2014 | 350 | 0.030 |
Why?
|
Placentation | 1 | 2012 | 82 | 0.030 |
Why?
|
Microarray Analysis | 1 | 2015 | 767 | 0.030 |
Why?
|
Vasodilation | 2 | 2006 | 944 | 0.030 |
Why?
|
Diet | 2 | 2010 | 7939 | 0.020 |
Why?
|
Mutation | 1 | 2016 | 29786 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2014 | 940 | 0.020 |
Why?
|
Longitudinal Studies | 2 | 2021 | 13989 | 0.020 |
Why?
|
Finland | 1 | 2012 | 602 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2011 | 475 | 0.020 |
Why?
|
Overweight | 1 | 2022 | 2371 | 0.020 |
Why?
|
Nucleosomes | 1 | 2014 | 494 | 0.020 |
Why?
|
Adolescent | 4 | 2024 | 85781 | 0.020 |
Why?
|
Cell Division | 1 | 1998 | 4568 | 0.020 |
Why?
|
Mice, 129 Strain | 1 | 2011 | 386 | 0.020 |
Why?
|
Acclimatization | 1 | 2010 | 103 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 3 | 2014 | 10943 | 0.020 |
Why?
|
Amino Acid Substitution | 1 | 2015 | 1791 | 0.020 |
Why?
|
Calorimetry, Indirect | 1 | 2010 | 183 | 0.020 |
Why?
|
Biological Transport | 2 | 2006 | 2118 | 0.020 |
Why?
|
Molecular Weight | 2 | 2005 | 2255 | 0.020 |
Why?
|
Glucose Clamp Technique | 2 | 2000 | 266 | 0.020 |
Why?
|
Regulatory Elements, Transcriptional | 1 | 2010 | 186 | 0.020 |
Why?
|
Sterol Regulatory Element Binding Protein 1 | 1 | 2009 | 137 | 0.020 |
Why?
|
CCAAT-Enhancer-Binding Protein-alpha | 1 | 2009 | 130 | 0.020 |
Why?
|
Chromans | 1 | 2008 | 122 | 0.020 |
Why?
|
HeLa Cells | 1 | 2015 | 3128 | 0.020 |
Why?
|
Syndrome | 1 | 2015 | 3251 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
Prospective Studies | 2 | 2023 | 53288 | 0.020 |
Why?
|
Gene Knockout Techniques | 1 | 2011 | 809 | 0.020 |
Why?
|
Life Style | 1 | 2019 | 3835 | 0.020 |
Why?
|
Myoblasts | 1 | 2008 | 238 | 0.020 |
Why?
|
Pancreatitis | 1 | 2014 | 1092 | 0.020 |
Why?
|
Embryonic Development | 1 | 2012 | 711 | 0.020 |
Why?
|
Carcinoma, Renal Cell | 1 | 2002 | 3143 | 0.020 |
Why?
|
Species Specificity | 1 | 2011 | 2478 | 0.020 |
Why?
|
Captopril | 1 | 2007 | 272 | 0.020 |
Why?
|
Drug Implants | 1 | 2007 | 244 | 0.020 |
Why?
|
Child | 4 | 2019 | 77709 | 0.020 |
Why?
|
Lipoprotein Lipase | 1 | 2006 | 126 | 0.020 |
Why?
|
Kidney Glomerulus | 1 | 2008 | 697 | 0.020 |
Why?
|
Peroxisomes | 1 | 2006 | 58 | 0.020 |
Why?
|
Kidney Neoplasms | 1 | 2002 | 4262 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2015 | 4204 | 0.020 |
Why?
|
Deoxyglucose | 1 | 2006 | 337 | 0.020 |
Why?
|
Rats, Inbred Lew | 1 | 2007 | 1162 | 0.020 |
Why?
|
Child, Preschool | 2 | 2019 | 41006 | 0.020 |
Why?
|
Intraoperative Care | 1 | 2009 | 767 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2014 | 3200 | 0.020 |
Why?
|
Sex Factors | 1 | 2018 | 10397 | 0.020 |
Why?
|
Embryo, Mammalian | 1 | 2010 | 1701 | 0.020 |
Why?
|
Creatine Kinase | 1 | 2006 | 694 | 0.010 |
Why?
|
Temperature | 1 | 2010 | 2206 | 0.010 |
Why?
|
Brachial Artery | 1 | 2005 | 369 | 0.010 |
Why?
|
Glucosidases | 1 | 2002 | 13 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2010 | 2715 | 0.010 |
Why?
|
Databases, Genetic | 1 | 2010 | 1783 | 0.010 |
Why?
|
Electron Transport Complex III | 1 | 2002 | 31 | 0.010 |
Why?
|
Electron Transport Complex II | 1 | 2002 | 48 | 0.010 |
Why?
|
Cyclic AMP Response Element-Binding Protein | 1 | 2005 | 514 | 0.010 |
Why?
|
Blotting, Western | 1 | 2010 | 5179 | 0.010 |
Why?
|
Mitochondrial Proton-Translocating ATPases | 1 | 2002 | 52 | 0.010 |
Why?
|
NADH, NADPH Oxidoreductases | 1 | 2002 | 93 | 0.010 |
Why?
|
Streptozocin | 1 | 2002 | 196 | 0.010 |
Why?
|
Rats, Long-Evans | 1 | 2003 | 387 | 0.010 |
Why?
|
Electron Transport Complex IV | 1 | 2002 | 189 | 0.010 |
Why?
|
Genes | 1 | 2006 | 1893 | 0.010 |
Why?
|
Protein Kinase C | 1 | 2007 | 1227 | 0.010 |
Why?
|
Procollagen | 1 | 2002 | 185 | 0.010 |
Why?
|
Succinate Dehydrogenase | 1 | 2002 | 146 | 0.010 |
Why?
|
Electron Transport Complex I | 1 | 2002 | 140 | 0.010 |
Why?
|
Gene Regulatory Networks | 1 | 2010 | 1708 | 0.010 |
Why?
|
Tumor Cells, Cultured | 1 | 2009 | 6314 | 0.010 |
Why?
|
Wnt Proteins | 1 | 2005 | 721 | 0.010 |
Why?
|
Models, Biological | 2 | 2010 | 9583 | 0.010 |
Why?
|
Genetic Linkage | 1 | 2006 | 2421 | 0.010 |
Why?
|
Orchiectomy | 1 | 2003 | 474 | 0.010 |
Why?
|
Thiobarbituric Acid Reactive Substances | 1 | 2000 | 46 | 0.010 |
Why?
|
Quantitative Trait Loci | 1 | 2008 | 2019 | 0.010 |
Why?
|
Liver Diseases | 1 | 2009 | 1253 | 0.010 |
Why?
|
Ovariectomy | 1 | 2003 | 661 | 0.010 |
Why?
|
Calcium-Binding Proteins | 1 | 2005 | 1081 | 0.010 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2007 | 1518 | 0.010 |
Why?
|
Mice, Inbred Strains | 1 | 2003 | 1827 | 0.010 |
Why?
|
Oxidoreductases | 1 | 2002 | 424 | 0.010 |
Why?
|
Lipoproteins | 1 | 2005 | 878 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2002 | 563 | 0.010 |
Why?
|
Anaerobic Threshold | 1 | 1999 | 52 | 0.010 |
Why?
|
Reference Values | 1 | 2007 | 4982 | 0.010 |
Why?
|
Enhancer Elements, Genetic | 1 | 2006 | 1341 | 0.010 |
Why?
|
Iodine Radioisotopes | 1 | 2003 | 1032 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2002 | 686 | 0.010 |
Why?
|
Young Adult | 2 | 2015 | 56430 | 0.010 |
Why?
|
Cerebral Cortex | 1 | 2015 | 5708 | 0.010 |
Why?
|
Adenosine Triphosphatases | 1 | 2002 | 839 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 2002 | 13102 | 0.010 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2000 | 473 | 0.010 |
Why?
|
Immunosorbent Techniques | 1 | 1997 | 184 | 0.010 |
Why?
|
Cell Membrane | 1 | 2007 | 3748 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2004 | 2126 | 0.010 |
Why?
|
Nerve Degeneration | 1 | 2001 | 748 | 0.010 |
Why?
|
Evidence-Based Medicine | 1 | 2009 | 3610 | 0.010 |
Why?
|
RNA | 1 | 2007 | 2749 | 0.010 |
Why?
|
Membrane Proteins | 2 | 2005 | 7880 | 0.010 |
Why?
|
Patient Selection | 1 | 2009 | 4215 | 0.010 |
Why?
|
Collagen | 1 | 2005 | 2689 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2002 | 1338 | 0.010 |
Why?
|
Risk Assessment | 2 | 2009 | 23338 | 0.010 |
Why?
|
Cholesterol, LDL | 1 | 2005 | 2356 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2008 | 11366 | 0.010 |
Why?
|
Promoter Regions, Genetic | 1 | 2006 | 5867 | 0.010 |
Why?
|
Infusions, Intravenous | 1 | 1999 | 2274 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2001 | 35421 | 0.010 |
Why?
|
Leg | 1 | 1999 | 1116 | 0.010 |
Why?
|
Coronary Disease | 1 | 2009 | 6077 | 0.010 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 1 | 1995 | 489 | 0.010 |
Why?
|
Internet | 1 | 2006 | 3064 | 0.010 |
Why?
|
Heart Diseases | 1 | 2006 | 2788 | 0.010 |
Why?
|
Ultrasonography | 1 | 2005 | 5985 | 0.010 |
Why?
|
Software | 1 | 2006 | 4443 | 0.010 |
Why?
|
Cytokines | 1 | 2005 | 7322 | 0.010 |
Why?
|
Atherosclerosis | 1 | 2005 | 3445 | 0.010 |
Why?
|
Protein-Tyrosine Kinases | 1 | 1995 | 2455 | 0.000 |
Why?
|
Rats, Sprague-Dawley | 1 | 1997 | 8301 | 0.000 |
Why?
|
United States | 1 | 2005 | 69872 | 0.000 |
Why?
|